Summary
Dose-response curves for heart rate, arterial blood pressure, cardiac output, total peripheral resistance, systolic time intervals, forearm blood flow and forearm vascular resistance were obtained after i.v. administration of seven logarithmically increasing doses of xamoterol to 8 healthy volunteers. The total cumulative dose was 0.2 mg/kg b.w. At rest after the seventh dose of xamoterol heart rate, systolic blood, pressure, cardiac output and forearm blood flow were increased by 10%, 20%, 23% and 41%, respectively. Diastolic blood pressure was unchanged. Forearm vascular resistance was reduced by 21% and total peripheral resistance by 10%. Systolic time intervals were reduced: total electromechanical systole index (QS2I), left ventricular ejection time index (LVETI), pre ejection period index (PEPI) and PEP/LVET ratio by 4%, 2%, 12% and 14%, respectively. No side-effects were observed. During upright exercise after the seventh dose of xamoterol heart rate was reduced by 11% and systolic BP by 6%. Diastolic blood pressure was unchanged. Thus xamoterol increased the contractility of the heart with only a small increase in heart rate, increased systolic blood pressure and caused vasodilatation in resting skeletal muscle. During exercise the reduction in heart rate and blood pressure suggests beta-adrenoceptor blocking activity of the drug.
Similar content being viewed by others
References
Barlow JJ, Main BG, Moors JA, Nuttal A, Snow HM (1979) The cardiovascular activity of ICI 118.587 a novel beta-adrenoceptor partial agonist. Br J Pharmacol 67: 412P
Barlow JT, Main BG, Snow HM (1981) Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propranols. J Med Chem 24: 315–322
Dodge HT, Lord JD, Sandler H (1960) Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure. Am Heart J 60: 94–105
Hallböök T, Månsson B, Nilsen RA (1970) A strain gauge plethysmograph with electrical calibration. Scand J Clin Lab Invest 25: 413–418
Johnsson G, Jordö L, Lundborg P, Rönn O Welin-Fogelberg I, Wikstrand J (1978) Haemodynamic and tolerance studies in man of a new orally active, selective beta1-adrenoceptor agonist H 80/62. Eur J Clin Pharmacol 13: 163–170
Kubicek WG, Kottke FJ, Ramos MU, Patterson RP, Witsoe DA, Labree JW, Remole W, Laymann TE, Schoening H, Garamella JT (1974) The Minnesota impedance cardiograph — theory and applications. Biomed Eng 9: 410–416
Marlow HF, Wardleworth AG, Booth LM (1982) The haemodynamic effects of oral doses of ICI 118.587, a beta-adrenoceptor partial agonist, in healthy volunteers. Br J Clin Pharmacol 13: 269P-270P
Nelson RR, Globel FL, Jorgensen GR, Wang K, Wang Y, Taylor HL (1974) Haemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50: 1179–1189
Nuttal A, Snow HM (1982) The cardiovascular effects of ICI 118.587: A β1-adrenoceptor partial agonist. Br J Pharmacol 77: 381–388
Pouleur H, Rousseau MF, Mengeot P, Veriter C, Vincent MF, Brasseur LA (1982) Improvement of global function in patients with previous myocardial infarction by a new beta1-adrenoceptor partial agonist, ICI 118.587. Eur Heart J 3 [Suppl D]: 123–127
Sonnenblick FH, Frishmann WH, LeJemtal TH (1979) Dobutamine: A new sympathetic amine. N Engl J Med 300: 17–22
Svendsen TL, Hartling OJ, Trap-Jensen J (1980) Immediate haemodynamic effects of prenalterol a new adrenergic beta1-receptor agonist, in healthy volunteers. Eur J Clin Pharmacol 18: 219–223
Weissler AM, Harris WS, Schoenfeld CD (1969) Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 23: 577–583
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tangø, M., Carlsen, J.E. & Trap-Jensen, J. Immediate central and regional haemodynamic effects of a new beta1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers. Eur J Clin Pharmacol 29, 155–158 (1985). https://doi.org/10.1007/BF00547414
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00547414